MedTrace Logo

Antifungal Potential of Moringa Olifera Against Otomycosis

NCT04768829 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2022-03-09

No results posted yet for this study

Summary

patients with Otomycosis were recognized by an ENT specialist. 20 patients were distributed randomly into two groups. The first group will be treated with Nystatin ear drops twice daily. The second group will be treated with Moringa ear drops. patients will be examined endoscopically by the ENT specialist. patient's swabs will be isolated and analyzed by ELISA.

Conditions

  • Otomycosis

Interventions

DRUG

Moringa oleifera leaf 10mg/100ml

ear drops

DRUG

Ear Drop

plain ear drop formulation without moringa

Sponsors & Collaborators

  • Minia University

    collaborator OTHER

  • Deraya University

    lead OTHER

Principal Investigators

  • Soad A Mohamad · Deraya University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-02-18
Primary Completion
2021-09-15
Completion
2021-12-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04768829 on ClinicalTrials.gov